Market Wire - Endo Licenses U.S. Rights for Voltaren(R) Gel -- the First FDA-Approved Topical Treatment for Relief of Osteoarthritis Pain

Published on: Tue, 04 Mar 2008 08:00:00 GMT

March 4, 2008 -- Endo Pharmaceuticals Inc., a wholly ownedsubsidiary of Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP) and amarket leader in pain management,... More »